ElevateBio
PrivateLast Round
Series D
5/24/2023
Total Funding Raised
$1.2B
Company Overview
ElevateBio is a biotechnology company focused on developing, manufacturing, and commercializing life-changing cell and gene therapies through strategic partnerships and a centralized facility that streamlines the translation of research into effective treatments for severe diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clean Manufacturing, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ElevateBio Comps
Public and private peers based on sector, stage, and business model.
ElevateBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | 5/24/2023 | ||||
| Series C | 3/15/2021 | ||||
| Series B | 3/30/2020 | ||||
| Series A | 5/13/2019 |
Key People
Founding team and executive leadership
ElevateBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EcoR1 Capital | Series B, Series A, Series D, Series C |
| Redmile Group | Series B, Series A, Series D, Series C |
| MPM Capital | Series B, Series D, Series C, Series A |
| SoftBank Investment Advisers | Series D, Series C |
| Fidelity Management & Research Company | Series D, Series C |
| SoftBank Vision Fund 2 | Series D, Series C |
| MPM BioImpact | Series A, Series B, Series D, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 5, 2026
Christopher Murphy named Chief Executive Officer and Board member.
- Jan 5, 2026
Chris appointed as the new Executive Chairman.
ElevateBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ElevateBio's valuation, stock price, and market status.
